CYCN earnings date and last-quarter result: last quarter beat, P/E -2.56. Updated 2026-07-23.
Cyclerion Therapeutics (CYCN) Research Hub
Cyclerion Therapeutics (CYCN) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-08, shares last closed at 23.52 USD (-20.94%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.56, market cap 0.02B. This hub links to the full technical, earnings and options research available for CYCN.
Last updated 2026-09-08 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 23.52 USD (-20.94%) |
| 52-week range | 19.74 USD – 36.33 USD |
| Trend regime | Range |
| 14-day RSI | 48.2 (Neutral) |
| Trailing P/E | -2.56 |
| Market cap | 0.02B |
| Dividend yield | 0.00% |
Available research for CYCN
Covered Call on CYCN: how it works, illustrative setup around the real 23.52 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CYCN: how it works, illustrative setup around the real 23.52 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CYCN: how it works, illustrative setup around the real 23.52 USD price, max profit/loss, breakeven and when to use it. Educational.
CYCN technical analysis: range, last 23.52 USD, RSI 48.2, 52w range 19.74 USD–36.33 USD, real support/resistance. Updated 2026-09-08.
More on SniperIQ
Frequently asked questions
What sector is CYCN in?
Cyclerion Therapeutics (CYCN) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is CYCN in an uptrend or downtrend?
As of 2026-09-08, CYCN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CYCN's trailing P/E ratio?
CYCN's trailing P/E is -2.56, with a market cap of 0.02B. See the earnings research page for full valuation detail.